openPR Logo
Press release

Compounding Pharmacies Market Forecasted to Reach US$ 9.7 Billion

07-07-2017 01:13 PM CET | Health & Medicine

Press release from: Persistence Market Research PVT. LTD.

Compounding Pharmacies Market Forecasted to Reach US$ 9.7

The global compounding pharmacies market is projected to expand at a CAGR of 6% during the forecast period (2015 - 2021). Compounding pharmacies accounted for market revenue worth US$ 6.5 Bn in 2014 and the revenue is expected to increase to US$ 9.75 Bn by 2021.

Compounding pharmacies produce personalized medicines, which can be altered by dosages, medicinal strengths, forms, and medium of administration, under the guidance of licensed pharmacists and physicians. The market for compounding pharmacies – though shrouded by regulatory restrictions and product quality conformations – presents a lucrative opportunity as compounded drugs offer ease of accessibility, affordability, and administration to potential customers. The report analyzes the global compounding pharmacies market in terms of market value by end use, product, region, and therapeutic area; and provides information regarding regional market dynamics, regulations, PEST analysis, competitive landscape, current trends, market estimations, and forecast.

Browse Complete Report @ http://www.persistencemarketresearch.com/market-research/compounding-pharmacies-market.asp

Among therapeutic segments, compounding pharmacies find largest application in the pain management industry followed by hormone replacement therapy and others. The hormone replacement therapy segment is expected to gain traction in the near future due to increasing demand for anti-ageing solutions. Increasing demand for high-quality dermatological products is also influencing manufacturers to opt for better quality active pharmaceutical ingredients and maintain a sterile microbial contamination-free manufacturing space. Creams and gels are the most popular products in dermatology, followed by transdermal application products, largely popular in tropical countries.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/5270

By end use type, the compounding pharmacies market is segmented into medications for adults, children, and geriatric population along with veterinary drugs. Medications for the adult segment is expected to dominate the overall compounding pharmacies market by the end of the forecast period. The segment is projected to register an above average growth rate over the forecast period. However, veterinary compounded drugs are also gaining traction as these drugs are available in alternate forms and in varying strengths not commercially available.

Globally, Asia Pacific is expected to dominate the market throughout the forecast period, driven by the promotion of innovative therapies and product formulations by major players in the market. Singapore and Australia are the two major growth promoting countries for compounding pharmacies in Asia Pacific. The compounding pharmacies market in Singapore is expected to increase from a current estimated value of US$ 204.9 Mn in 2015 to US$ 387.2 Mn by 2021, registering a CAGR of 11% over the forecast period. Increase in demand for drugs prone to medicinal drought, personalized dosages, and innovative therapeutic areas is expected to boost overall demand for compounding pharmacies worldwide. Upcoming regulatory harmonization and the need for manufacturing facilities to adhere to good manufacturing practices listed under the U.S. and EU pharmacopeias are set to standardize the compounding pharmacies market. Compounded drug manufacturers in Australia have been mandated to adhere by rules listed under the Australian Therapeutic Goods Administration (TGA). Latin America and Europe are the subsequent lucrative destinations for compounding pharmacies.

Request to view table of content @ http://www.persistencemarketresearch.com/market-research/compounding-pharmacies-market/toc

Key market players covered in the report include B. Braun Melsungen AG Company, Fagron, PharMEDium Services LLC, Institutional Pharmacy Solutions, Cantrell Drug Company, Triangle Compounding Pharmacies, Lorraine’s Pharmacy, and Fresenius Kabi AG.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Compounding Pharmacies Market Forecasted to Reach US$ 9.7 Billion here

News-ID: 613400 • Views:

More Releases from Persistence Market Research PVT. LTD.

Battery Material Market is projected to reach a valuation of US$ 110.02 billion by 2027
Battery Material Market is projected to reach a valuation of US$ 110.02 billion …
The battery material market has witnessed significant growth in recent years, driven by the increasing demand for batteries in various applications. According to recent studies, the market was valued at USD 42.1 billion in 2022 and is projected to reach USD 110.02 billion by 2027, growing at a CAGR of 14.1% during the forecast period. Click Here to Get Free Sample Copy of this Report@https://www.persistencemarketresearch.com/samples/10801 The battery material market encompasses a wide
Automated Intralogistics Material Handling Solutions Market to Hit US$ 219.3 billion by 2033
Automated Intralogistics Material Handling Solutions Market to Hit US$ 219.3 b …
Automated intralogistics material handling solution sales are anticipated to achieve a global market value of US$ 55.9 billion in 2023 and to grow steadily at a CAGR of 14.8% to reach US$ 219.3 billion by 2033. The global intralogistics material handling solutions market is experiencing a revolution with the introduction of automated systems. Automation has become a game-changer, offering greater efficiency and productivity to businesses across the globe. The market for automated intralogistics material handling solutions is projected to witness impressive growth in the coming years. Click Here to Get Free Sample Copy of this Report@https://www.persistencemarketresearch.com/samples/32829 The key drivers for the growth of the automated intralogistics material handling
Cold Chain Market is Encouraged to Reach USD 474.29 billion by 2028
Cold Chain Market is Encouraged to Reach USD 474.29 billion by 2028
The global cold chain market size was valued at USD 211.77 billion in 2020 and is expected to reach USD 474.29 billion by 2028, growing at a CAGR of 9.7% from 2021 to 2028. The growth is driven by increasing demand for perishable goods, globalization of the food trade, and technological advancements in cold chain logistics. Click Here to Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3177 The cold chain market refers
Automated Intralogistics Material Handling Solutions Market Value to Hit US$ 219.3 Bn by 2033
Automated Intralogistics Material Handling Solutions Market Value to Hit US$ 219 …
𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐞𝐝 𝐈𝐧𝐭𝐫𝐚𝐥𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐭𝐞𝐫𝐢𝐚𝐥 𝐇𝐚𝐧𝐝𝐥𝐢𝐧𝐠 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧 𝟐𝟎𝟐𝟑, 𝐬𝐚𝐥𝐞𝐬 𝐨𝐟 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐞𝐝 𝐢𝐧𝐭𝐫𝐚𝐥𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬 𝐦𝐚𝐭𝐞𝐫𝐢𝐚𝐥 𝐡𝐚𝐧𝐝𝐥𝐢𝐧𝐠 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒$ 𝟓𝟓.𝟗 𝐁𝐧 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐞𝐱𝐩𝐚𝐧𝐝 𝐬𝐭𝐞𝐚𝐝𝐢𝐥𝐲 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟒.𝟖% 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐚 𝐦𝐚𝐫𝐤𝐞𝐭 𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐜𝐥𝐨𝐬𝐞 𝐭𝐨 𝐔𝐒$ 𝟐𝟏𝟗.𝟑 𝐁𝐧 𝐛𝐲 𝟐𝟎𝟑𝟑. The demand in Germany is expected to increase by 15.7% CAGR from 2024 to 2033 on a value basis. U.S., China, and Germany are the leading countries in the

All 5 Releases


More Releases for Compounding

NBR Compounding Market Report Status And Outlook 2022-2027-Hexpol Compounding, P …
The NBR Compounding Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global
Compounding Pharmacies Market 2020: Top Key Players Are Triangle Compounding Pha …
Industry Overview: Updated research report on Compounding Pharmacies Market by ‘Market Growth Insight’ delivers pivotal information on the market including drivers, restraints, challenges, and opportunities. The Compounding Pharmacies report is useful to business owners, manufacturers, distributors, suppliers, marketing personnel, strategists, and customers since it helps them to understand the current market scenario and make future planning, while considering the risks that are also mentioned in the report. The Compounding Pharmacies report
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is
U.S. Compounding Pharmacies Market ; Eminent Players - Pencol Compounding Pharma …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is
U.S. Compounding Pharmacies Market Key Players – McKesson Corporation, Nephron …
U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc. Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured